187 related articles for article (PubMed ID: 27000279)
1. Cost avoidance from dose rounding biologic and cytotoxic antineoplastics.
Vandyke TH; Athmann PW; Ballmer CM; Kintzel PE
J Oncol Pharm Pract; 2017 Jul; 23(5):379-383. PubMed ID: 27000279
[TBL] [Abstract][Full Text] [Related]
2. Cost savings from dose rounding of biologic anticancer agents in adults.
Winger BJ; Clements EA; DeYoung JL; O'Rourke TJ; Claypool DL; Vachon S; VanDyke TH; Zimmer-Young J; Kintzel PE
J Oncol Pharm Pract; 2011 Sep; 17(3):246-51. PubMed ID: 20332175
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.
Chillari KA; Southward J; Harrigan N
J Oncol Pharm Pract; 2018 Oct; 24(7):507-510. PubMed ID: 28732452
[TBL] [Abstract][Full Text] [Related]
4. Rounding rituximab dose to nearest vial size.
Patel S; Le A
J Oncol Pharm Pract; 2013 Sep; 19(3):218-21. PubMed ID: 23114093
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the dosing strategies of biologic agents and the theoretical impact of dose rounding.
Lindsey S; Parsons LB; Figg LR; Rhodes J
J Oncol Pharm Pract; 2018 Jan; 24(1):47-55. PubMed ID: 29251257
[TBL] [Abstract][Full Text] [Related]
6. Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology/Oncology Pharmacy Association.
Fahrenbruch R; Kintzel P; Bott AM; Gilmore S; Markham R
J Oncol Pract; 2018 Mar; 14(3):e130-e136. PubMed ID: 29400987
[TBL] [Abstract][Full Text] [Related]
7. Financial Impact of an Automated Oncology Dose-Rounding Initiative: One-Year Analysis.
Dela-Pena JC; Eschenburg KA; LaRocca VW; Patel D; Hough SM
JCO Clin Cancer Inform; 2021 Aug; 5():805-810. PubMed ID: 34351786
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution.
Graff JM; Cramer J; Kolb LL; Agherrabi Z; Burgess M
J Oncol Pharm Pract; 2024 Jun; 30(4):705-709. PubMed ID: 37350075
[TBL] [Abstract][Full Text] [Related]
9. Implications of dose rounding of chemotherapy to the nearest vial size.
Dooley MJ; Singh S; Michael M
Support Care Cancer; 2004 Sep; 12(9):653-6. PubMed ID: 14986078
[TBL] [Abstract][Full Text] [Related]
10. Potential cost savings associated with dose rounding antineoplastic monoclonal agents.
Francis SM; Heyliger A; Miyares MA; Viera M
J Oncol Pharm Pract; 2015 Aug; 21(4):280-4. PubMed ID: 24821690
[TBL] [Abstract][Full Text] [Related]
11. Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
Copur MS; Gnewuch C; Schriner M; Tharnish M; Gonen M; McDonald M; Kezeor J; Ramaekers RC; Gauchan D; Clark D; Greenwalt L; Mickey M; Norvell M
J Oncol Pharm Pract; 2018 Mar; 24(2):116-120. PubMed ID: 29284380
[TBL] [Abstract][Full Text] [Related]
12. Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center.
Moore DC; McVey GN
J Oncol Pharm Pract; 2018 Jan; 24(1):42-46. PubMed ID: 27760811
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a standardised pharmacist check of medical orders prior to preparation of anticancer drugs to reduce drug wastage.
Yamada H; Kobayashi R; Shimizu S; Yamada Y; Ishida M; Shimoda H; Kato-Hayashi H; Fujii H; Iihara H; Tanaka H; Suzuki A
Int J Clin Pract; 2020 Apr; 74(4):e13464. PubMed ID: 31830345
[TBL] [Abstract][Full Text] [Related]
14. [Lower costs for anticancer drugs by safety margin around calculated dose and by fine-tuning on ampoule strength].
Mertens S; de Jongh FE
Ned Tijdschr Geneeskd; 2009; 153():B162. PubMed ID: 19785801
[TBL] [Abstract][Full Text] [Related]
15. A real-world data approach to determine the optimal dosing strategy for pembrolizumab.
Jang A; Nakashima L; Ng T; Fung M; Jiwani S; Schaff K; Suess J; Goncalves R; Jang D; Kuik K; Labelle S; Pow A
J Oncol Pharm Pract; 2021 Apr; 27(3):635-643. PubMed ID: 32539663
[TBL] [Abstract][Full Text] [Related]
16. Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record system.
Shah V; Spence A; Bartels T; Betcher J; Soefje S
Am J Health Syst Pharm; 2022 Apr; 79(8):676-682. PubMed ID: 34940791
[TBL] [Abstract][Full Text] [Related]
17. Dose standardisation of anticancer drugs.
Pouliquen AL; Escalup L; Jourdan N; Cottu P; Faure P; Madelaine-Chambrin I
Int J Clin Pharm; 2011 Apr; 33(2):221-8. PubMed ID: 21369959
[TBL] [Abstract][Full Text] [Related]
18. Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology.
El Baraka S; Cherif Chefchaouni A; Bourdaime A; Ouedraogo JM; Shytry O; Belahcen MJ; Rahali Y
J Oncol Pharm Pract; 2023 Sep; ():10781552231203403. PubMed ID: 37728162
[TBL] [Abstract][Full Text] [Related]
19. Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings.
Jarkowski A; Nestico JS; Vona KL; Khushalani NI
J Oncol Pharm Pract; 2014 Feb; 20(1):47-50. PubMed ID: 23512270
[TBL] [Abstract][Full Text] [Related]
20. Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation Strategies.
Leung CYW; Cheung MC; Charbonneau LF; Prica A; Ng P; Chan KKW
J Oncol Pract; 2017 Jul; 13(7):e646-e652. PubMed ID: 28605255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
